Zinc for Osteoporosis
The relationship between Zinc and Osteoporosis is moderately strong. Zinc ranks 14 of 299 Osteoporosis treatments on our list.
Osteoporosis ("porous bones", from Greek: οστούν/ostoun meaning "bone" and πόρος/poros meaning "pore") is a progressive bone disease that is characterised by a decrease in bone mass and density and that leads to an increased risk of fracture. Zinc, in commerce also spelter, is a metallic chemical element; it has the symbol Zn and atomic number 30.
Strength of evidence
Zinc for Osteoporosis ranks in the top 57% of condition-treatment relationships we have analyzed. (The higher the number, the stronger the evidence.)
Of research analyzed, we found 41 studies on people and 38 studies on animals. Importantly, we found only 1 study that was randomized and controlled. Such studies are considered the most rigorous, and help to establish or disprove a cause-and-effect relationship between prospective treatments and conditions. So there may be some good evidence on which to make a decision about using this treatment.
Here's how Zinc compares to other Osteoporosis treatments we analyzed, as well as to all condition-treatment relationships:
The relationship between Osteoporosis and Zinc has been little researched. We found at least 257 research articles on the topic. This places the volume of research in the top 21% of relationships we have analyzed between treatments and conditions. The pace of research appears to be increasing:
Important caveat—help improve this information
Please note that our analysis is automated and imperfect. If you have personal insight, please help improve our analysis by rating this relationship and the research supporting it. And check back regularly; we last analyzed research for this relationship on Mar 7, 2014, and are constantly updating our database and algorithms.